nodes	percent_of_prediction	percent_of_DWPC	metapath
Tocainide—SCN7A—cardiac atrium—muscle cancer	0.0367	0.0666	CbGeAlD
Tocainide—SCN11A—head—muscle cancer	0.0322	0.0585	CbGeAlD
Tocainide—SCN4A—renal system—muscle cancer	0.0286	0.0519	CbGeAlD
Tocainide—SCN7A—head—muscle cancer	0.0274	0.0497	CbGeAlD
Tocainide—SCN7A—testis—muscle cancer	0.0265	0.048	CbGeAlD
Tocainide—SCN9A—tendon—muscle cancer	0.025	0.0454	CbGeAlD
Tocainide—SCN8A—head—muscle cancer	0.0244	0.0443	CbGeAlD
Tocainide—SCN8A—testis—muscle cancer	0.0236	0.0428	CbGeAlD
Tocainide—SCN4A—tendon—muscle cancer	0.0223	0.0405	CbGeAlD
Tocainide—SCN3A—renal system—muscle cancer	0.0223	0.0404	CbGeAlD
Tocainide—SCN9A—testis—muscle cancer	0.0207	0.0376	CbGeAlD
Tocainide—SCN5A—cardiac atrium—muscle cancer	0.0199	0.0361	CbGeAlD
Tocainide—SCN4A—head—muscle cancer	0.0192	0.0347	CbGeAlD
Tocainide—SCN4A—testis—muscle cancer	0.0185	0.0336	CbGeAlD
Tocainide—SCN1A—head—muscle cancer	0.0185	0.0335	CbGeAlD
Tocainide—SCN2A—vagina—muscle cancer	0.0184	0.0333	CbGeAlD
Tocainide—SCN3A—tendon—muscle cancer	0.0174	0.0315	CbGeAlD
Tocainide—SCN2A—head—muscle cancer	0.017	0.0307	CbGeAlD
Tocainide—SCN3A—bone marrow—muscle cancer	0.0168	0.0305	CbGeAlD
Tocainide—SCN10A—head—muscle cancer	0.0163	0.0297	CbGeAlD
Tocainide—SCN3A—vagina—muscle cancer	0.0161	0.0293	CbGeAlD
Tocainide—SCN5A—vagina—muscle cancer	0.0161	0.0292	CbGeAlD
Tocainide—SCN7A—Developmental Biology—MYF6—muscle cancer	0.0155	0.0345	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—MYF5—muscle cancer	0.0155	0.0345	CbGpPWpGaD
Tocainide—SCN3A—head—muscle cancer	0.0149	0.027	CbGeAlD
Tocainide—SCN5A—head—muscle cancer	0.0149	0.0269	CbGeAlD
Tocainide—SCN3A—testis—muscle cancer	0.0144	0.0261	CbGeAlD
Tocainide—SCN11A—Developmental Biology—MYF6—muscle cancer	0.0138	0.0307	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—MYF5—muscle cancer	0.0138	0.0307	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—MYF6—muscle cancer	0.0126	0.0281	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—MYF5—muscle cancer	0.0126	0.0281	CbGpPWpGaD
Tocainide—CYP1A2—renal system—muscle cancer	0.0117	0.0212	CbGeAlD
Tocainide—ALB—testis—muscle cancer	0.0115	0.0208	CbGeAlD
Tocainide—SCN9A—Developmental Biology—MYF5—muscle cancer	0.0102	0.0227	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—MYF6—muscle cancer	0.0102	0.0227	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—MYOG—muscle cancer	0.00997	0.0222	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MYF6—muscle cancer	0.00976	0.0217	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MYF5—muscle cancer	0.00976	0.0217	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MYF5—muscle cancer	0.00938	0.0209	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MYF5—muscle cancer	0.00938	0.0209	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MYF6—muscle cancer	0.00938	0.0209	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MYF6—muscle cancer	0.00938	0.0209	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MYF5—muscle cancer	0.00904	0.0201	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MYF5—muscle cancer	0.00904	0.0201	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MYF6—muscle cancer	0.00904	0.0201	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MYF6—muscle cancer	0.00904	0.0201	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—MYOG—muscle cancer	0.00889	0.0198	CbGpPWpGaD
Tocainide—SCN5A—Cardiac Progenitor Differentiation—IGF2—muscle cancer	0.00823	0.0183	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—MYOG—muscle cancer	0.00813	0.0181	CbGpPWpGaD
Tocainide—SCN5A—SIDS Susceptibility Pathways—TP73—muscle cancer	0.00781	0.0174	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—MYOG—muscle cancer	0.00658	0.0147	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MYF6—muscle cancer	0.00636	0.0142	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MYF5—muscle cancer	0.00636	0.0142	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MYOG—muscle cancer	0.00629	0.014	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—MYOD1—muscle cancer	0.00616	0.0137	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MYOG—muscle cancer	0.00604	0.0135	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MYOG—muscle cancer	0.00604	0.0135	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MYOG—muscle cancer	0.00583	0.013	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MYOG—muscle cancer	0.00583	0.013	CbGpPWpGaD
Tocainide—SCN5A—Cardiac Progenitor Differentiation—KIT—muscle cancer	0.00577	0.0129	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—MED12—muscle cancer	0.00564	0.0126	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—MYOD1—muscle cancer	0.00549	0.0122	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—MED12—muscle cancer	0.00502	0.0112	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—MYOD1—muscle cancer	0.00502	0.0112	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—MED12—muscle cancer	0.00459	0.0102	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MYOG—muscle cancer	0.0041	0.00913	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—MYOD1—muscle cancer	0.00406	0.00905	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MYOD1—muscle cancer	0.00389	0.00866	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MYOD1—muscle cancer	0.00373	0.00832	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MYOD1—muscle cancer	0.00373	0.00832	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—MED12—muscle cancer	0.00372	0.00828	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MYOD1—muscle cancer	0.0036	0.00802	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MYOD1—muscle cancer	0.0036	0.00802	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—MED12—muscle cancer	0.00355	0.00792	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—MED12—muscle cancer	0.00341	0.00761	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—MED12—muscle cancer	0.00341	0.00761	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—MED12—muscle cancer	0.00329	0.00734	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—MED12—muscle cancer	0.00329	0.00734	CbGpPWpGaD
Tocainide—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	0.00324	0.00722	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—FOXO1—muscle cancer	0.00309	0.00689	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—FOXO1—muscle cancer	0.00276	0.00614	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MYOD1—muscle cancer	0.00253	0.00564	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—FOXO1—muscle cancer	0.00252	0.00562	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—MED12—muscle cancer	0.00231	0.00516	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—IGF2—muscle cancer	0.00223	0.00498	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	0.00213	0.00474	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—FOXO1—muscle cancer	0.00204	0.00454	CbGpPWpGaD
Tocainide—SCN7A—Axon guidance—VEGFA—muscle cancer	0.00198	0.0044	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—FOXO1—muscle cancer	0.00195	0.00435	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—FOXO1—muscle cancer	0.00187	0.00418	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—FOXO1—muscle cancer	0.00187	0.00418	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—FOXO1—muscle cancer	0.00181	0.00403	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—FOXO1—muscle cancer	0.00181	0.00403	CbGpPWpGaD
Tocainide—SCN11A—Axon guidance—VEGFA—muscle cancer	0.00176	0.00392	CbGpPWpGaD
Tocainide—SCN8A—Axon guidance—VEGFA—muscle cancer	0.00161	0.00359	CbGpPWpGaD
Tocainide—SCN5A—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.00146	0.00324	CbGpPWpGaD
Tocainide—SCN7A—Developmental Biology—VEGFA—muscle cancer	0.00141	0.00314	CbGpPWpGaD
Tocainide—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	0.00134	0.00299	CbGpPWpGaD
Tocainide—SCN9A—Axon guidance—VEGFA—muscle cancer	0.0013	0.0029	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.0013	0.00289	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—FOXO1—muscle cancer	0.00127	0.00283	CbGpPWpGaD
Tocainide—SCN11A—Developmental Biology—VEGFA—muscle cancer	0.00126	0.0028	CbGpPWpGaD
Tocainide—SCN3A—Axon guidance—VEGFA—muscle cancer	0.00125	0.00278	CbGpPWpGaD
Tocainide—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	0.00121	0.0027	CbGpPWpGaD
Tocainide—SCN2A—Axon guidance—VEGFA—muscle cancer	0.0012	0.00267	CbGpPWpGaD
Tocainide—SCN4A—Axon guidance—VEGFA—muscle cancer	0.0012	0.00267	CbGpPWpGaD
Tocainide—SCN1A—Axon guidance—VEGFA—muscle cancer	0.00115	0.00257	CbGpPWpGaD
Tocainide—SCN10A—Axon guidance—VEGFA—muscle cancer	0.00115	0.00257	CbGpPWpGaD
Tocainide—SCN8A—Developmental Biology—VEGFA—muscle cancer	0.00115	0.00256	CbGpPWpGaD
Tocainide—ALB—Selenium Micronutrient Network—PTGS2—muscle cancer	0.0011	0.00246	CbGpPWpGaD
Tocainide—ALB—Hemostasis—ANGPT2—muscle cancer	0.00105	0.00234	CbGpPWpGaD
Tocainide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.00102	0.00227	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000991	0.00221	CbGpPWpGaD
Tocainide—ALB—Platelet degranulation—VEGFA—muscle cancer	0.000937	0.00209	CbGpPWpGaD
Tocainide—SCN9A—Developmental Biology—VEGFA—muscle cancer	0.000929	0.00207	CbGpPWpGaD
Tocainide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	0.000892	0.00199	CbGpPWpGaD
Tocainide—SCN3A—Developmental Biology—VEGFA—muscle cancer	0.000889	0.00198	CbGpPWpGaD
Tocainide—SCN2A—Developmental Biology—VEGFA—muscle cancer	0.000854	0.0019	CbGpPWpGaD
Tocainide—SCN4A—Developmental Biology—VEGFA—muscle cancer	0.000854	0.0019	CbGpPWpGaD
Tocainide—ALB—Folate Metabolism—TP53—muscle cancer	0.000826	0.00184	CbGpPWpGaD
Tocainide—SCN10A—Developmental Biology—VEGFA—muscle cancer	0.000823	0.00184	CbGpPWpGaD
Tocainide—SCN1A—Developmental Biology—VEGFA—muscle cancer	0.000823	0.00184	CbGpPWpGaD
Tocainide—SCN5A—Axon guidance—VEGFA—muscle cancer	0.000811	0.00181	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.00078	0.00174	CbGpPWpGaD
Tocainide—ALB—Metabolism—FH—muscle cancer	0.000614	0.00137	CbGpPWpGaD
Tocainide—SCN5A—Developmental Biology—VEGFA—muscle cancer	0.000579	0.00129	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000545	0.00122	CbGpPWpGaD
Tocainide—ALB—Hemostasis—IGF2—muscle cancer	0.000511	0.00114	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—FH—muscle cancer	0.00043	0.000958	CbGpPWpGaD
Tocainide—ALB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000416	0.000926	CbGpPWpGaD
Tocainide—ALB—Metabolism—MED12—muscle cancer	0.000347	0.000774	CbGpPWpGaD
Tocainide—ALB—Metabolism—ENO2—muscle cancer	0.000317	0.000705	CbGpPWpGaD
Tocainide—ALB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000248	0.000552	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—MED12—muscle cancer	0.000243	0.000541	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—ENO2—muscle cancer	0.000221	0.000493	CbGpPWpGaD
Tocainide—ALB—Hemostasis—VEGFA—muscle cancer	0.000214	0.000477	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000173	0.000386	CbGpPWpGaD
Tocainide—ALB—Hemostasis—TP53—muscle cancer	0.000162	0.000361	CbGpPWpGaD
Tocainide—ALB—Metabolism—PTGS2—muscle cancer	0.00011	0.000246	CbGpPWpGaD
Tocainide—CYP1A2—Metabolism—PTGS2—muscle cancer	7.71e-05	0.000172	CbGpPWpGaD
